Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Ortega Morán
Institution:
Hospital General Universitario Gregorio Marañón
Observed institution:
Hospital General Universitario Gregorio Marañón
ORCID:
0000-0003-0456-7322
Observed ORCID:
0000-0003-0456-7322
OpenAlex ID:
A5130668983
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
·
Cancer Research Communications
·
10
PDF
Efficacy data of oxaliplatin retreatment in patients with metastatic colorectal cancer in a real-world setting.
2026
·
Javier Soto Alsar
, Andrés J. Muñoz Martín
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Study of Tumor Mutational Changes Assessed by NGS in Patients with BRAF-Mutated Metastatic Colorectal Cancer Undergoing Surgical Resection After Prior Systemic Therapy
2026
·
Javier Soto Alsar
, Coral Polo
, et al.
·
Preprints.org
Figure 1 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 1 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Figure 2 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 10 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Data Availability Statement from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Figure 4 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 6 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 5 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 9 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Table 5 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 3 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 4 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 8 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Table 1 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Table 7 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Figure 11 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Table 3 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Table 4 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Table 6 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Table 2 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Figure 3 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Supplementary Table 1 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
2026
·
Mariano Ponz-Sarvisé
, Sun Young Rha
, et al.
Show more works
View as search
Works count:
32
Citation count:
11
H-index:
1
I10-index:
1
Year
Topic
Type